Breast-feeding vs formula-feeding for infants born small-for-gestational-age: divergent effects on fat mass and on circulating IGF-I and high-molecular-weight adiponectin in late infancy

J Clin Endocrinol Metab. 2013 Mar;98(3):1242-7. doi: 10.1210/jc.2012-3480. Epub 2013 Jan 30.

Abstract

Context: Fetal growth restraint, if followed by rapid weight gain, confers risk for adult disease including diabetes. How breast-feeding may lower such risk is poorly understood. OBJECTIVE, STUDY PARTICIPANTS, INTERVENTION, OUTCOMES: In infants born small-for-gestational-age (SGA), we studied the effects of nutrition in early infancy (breast-feeding vs formula-feeding; BRF vs FOF) on weight partitioning and endocrine markers in late infancy. Body composition (by absorptiometry), fasting glycemia, insulin, IGF-I, and high-molecular-weight (HMW) adiponectin were assessed at 4 and 12 months in BRF controls born appropriate-for-GA (N = 31) and in SGA infants receiving BRF (N = 48) or FOF (N = 51), the latter being randomized to receive a standard formula (FOF1) or a protein-rich formula (FOF2).

Setting: The study was conducted in a University Hospital.

Results: SGA-BRF infants maintained a low fat mass and normal levels of IGF-I and HMW adiponectin. In contrast, SGA-FOF infants normalized their body composition by gaining more fat; this normalization was accompanied by a marked fall in HMW adiponectinemia and, in FOF2 infants, by elevated IGF-I levels. In late infancy, SGA-BRF infants were most sensitive to insulin, even more sensitive than appropriate-for-GA-BRF controls.

Conclusions: Because the health perspectives are better for SGA-BRF than for SGA-FOF infants, the present results suggest that FOF for SGA infants should aim at maintaining normal IGF-I and HMW-adiponectin levels rather than at normalizing body composition. Nutriceutical research for SGA infants may thus have to be redirected.

Publication types

  • Comparative Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adiponectin / blood*
  • Adiponectin / chemistry
  • Adipose Tissue / growth & development
  • Body Composition
  • Breast Feeding / methods*
  • Breast Feeding / statistics & numerical data
  • Diabetes Mellitus / epidemiology
  • Diabetes Mellitus / prevention & control
  • Female
  • Fetal Growth Retardation / diet therapy*
  • Fetal Growth Retardation / epidemiology
  • Fetal Growth Retardation / prevention & control
  • Follow-Up Studies
  • Humans
  • Hypertension / epidemiology
  • Hypertension / prevention & control
  • Infant
  • Infant Formula / administration & dosage*
  • Infant Formula / statistics & numerical data
  • Infant, Newborn
  • Infant, Small for Gestational Age / growth & development
  • Insulin-Like Growth Factor I / metabolism*
  • Longitudinal Studies
  • Male
  • Molecular Weight
  • Pregnancy
  • Prenatal Exposure Delayed Effects / diet therapy*
  • Prenatal Exposure Delayed Effects / epidemiology
  • Prenatal Exposure Delayed Effects / prevention & control
  • Risk Factors

Substances

  • ADIPOQ protein, human
  • Adiponectin
  • Insulin-Like Growth Factor I